← Open Payments lookup

CHRISTINA JONES: Open Payments

NPI 1184754723 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$40,698 in 117 payments from 11 companies in 2025. Trend: 2023 $701 · 2024 $739 · 2025 $40,698

Speaker / faculty: $29,165Travel & lodging: $8,867Food & beverage: $2,665
CompanyPaymentsAmount
Gilead Sciences, Inc.28$23,711
Indivior Inc.40$16,124
ABBVIE INC.15$258
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$182
Teva Pharmaceuticals USA, Inc.14$156
Neurocrine BioSciences, Inc.5$118
Braeburn Inc.2$40
Supernus Pharmaceuticals, Inc.2$33
E.R. Squibb & Sons, L.L.C.2$32
Vanda Pharmaceuticals Inc.1$23

Products named: Epclusa, SUBLOCADE, VRAYLAR, CAPLYTA, INGREZZA, AUSTEDO XR, UZEDY, BRIXADI.

Industry payments across LA — which companies pay providers there.